The analysis of genetically engineered variants of pp60c-src has permitted the definition of regions of the src protein (domains) that are involved in the regulations of normal c-src function and whose perturbation via mutagenesis results in the induction of the transformed phenotype. The overall aims of the experiments proposed in this application are three fold: 1) to extend our initial mutagenesis experiments and to use specific mutant forms of the c-src gene product to define the cellular proteins phosphorylated by pp60c-src, activated pp60c-src and pp60v-src; 2) to identify and characterize the cellular factors that regulate or modulate pp60c-src tyrosine protein kinase activity; and 3) to define the role of pp60c-src in the signal transduction pathway or other pathways the regulate cell growth. Using the regents generate during the first two years of the project, namely a series of transforming variants of c-src which induce various degrees of cellular transformation, we will seek to define cellular targets of the c-src protein. Three approaches will be utilized: a) cell fractionation techniques coupled with detection of tyrosine containing proteins; b) in vitro reconstitution of permeablized cells and membranes with purified proteins; c) genetic approaches that seek to identify cellular genes required for c-src function (in collaboration with M. Weber). We will continue to examine the role of Tyr 527 in the regulation of p60c-src activity and we will seek to identify cellular factors that may positively or negatively regulate pp60c-src activity, including other protein kinases. While pp60c-src has been implicated in the signal transduction pathway its position within this complicated molecular milieu remains to be defined. We propose to approach this problem by construction and utilization of a c-src replacement vector, a vector designed to suppress the resident pp60c-src and express a temperature sensitive form of the cellular src protein. Using such a vector, cell functions become dependent upon the expression f a thermolabile c-src protein whose activity can be modulated by temperature shift. Experimental manipulation of this system should provide insights as to the requirement of src function for cellular growth and mitogen/hormone responses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA040042-08
Application #
3795048
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Walters, Dustin M; Lindberg, James M; Adair, Sara J et al. (2013) Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. Neoplasia 15:143-55
Guerrero, Michael S; Parsons, J Thomas; Bouton, Amy H (2012) Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton. Genes Cancer 3:371-81
Owen, Katherine A; Abshire, Michelle Y; Tilghman, Robert W et al. (2011) FAK regulates intestinal epithelial cell survival and proliferation during mucosal wound healing. PLoS One 6:e23123
Ohama, Takashi; Brautigan, David L (2010) Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A. J Biol Chem 285:8711-8
Hall, Emily H; Balsbaugh, Jeremy L; Rose, Kristie L et al. (2010) Comprehensive analysis of phosphorylation sites in Tensin1 reveals regulation by p38MAPK. Mol Cell Proteomics 9:2853-63
Hall, Emily H; Daugherty, Abbi E; Choi, Colin K et al. (2009) Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion. J Biol Chem 284:34713-22
Molhoek, Kerrington R; McSkimming, Chantel C; Olson, Walter C et al. (2009) Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2. Cancer Immunol Immunother 58:867-76
Slack-Davis, Jill K; Hershey, E Daniel; Theodorescu, Dan et al. (2009) Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Ther 8:2470-7
Tilghman, Robert W; Parsons, J Thomas (2008) Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin Cancer Biol 18:45-52
Vomastek, Tomas; Iwanicki, Marcin P; Burack, W Richard et al. (2008) Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction. Mol Cell Biol 28:6954-66

Showing the most recent 10 out of 222 publications